Quanterix Corporation (QTRX) News
Filter QTRX News Items
QTRX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
QTRX News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest QTRX News From Around the Web
Below are the latest news stories about QUANTERIX CORP that investors may wish to consider to help them evaluate QTRX as an investment opportunity.
Quanterix Agrees to Acquire Akoya Biosciences in All-Stock DealQuanterix (QTRX) and Akoya Biosciences (AKYA) said Friday they entered into a definitive merger agre |
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein BiomarkersBILLERICA, Mass. and MARLBOROUGH, Mass., January 10, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced a definitive merger agreement under which Quanterix will acquire Akoya in an all-stock transaction. The transaction will create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers. |
David R. Walt Receives National Medal of Technology and InnovationBILLERICA, Mass., January 06, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inventor of the Company’s Simoa technology has received the National Medal of Technology and Innovation, bestowed by the President of the United States. |
Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBILLERICA, Mass., January 02, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the 43rd Annual J.P. Morgan Healthcare Conference taking place January 13th-16th at the Westin St. Francis Hotel in San Francisco, CA. Quanterix’s presentation will be on Wednesday, January 15, 2025, at 4:30 p.m., PST. In addition to the session, Quanter |
Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025Building up a strong portfolio requires a sharp eye for bargains. Investors have to know how to find the right stocks, at the right price – i.e. shares that are priced relatively low, but have sound prospects for sustained growth. In other words, to learn how to shop effectively at the discount racks of the equity world. Indeed, there are wide range of reasons that share prices can be down, ranging from simple bad luck to fundamental issues with the company. It’s okay to buy a stock that has sim |
Quanterix Expands Capabilities with Strategic Acquisition of EMISSIONBILLERICA, Mass., December 17, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the acquisition of EMISSION iNC. ("EMISSION"). Quanterix expects the transaction will close in January 2025. |
Quanterix Announces Receipt of Expected Notice from NasdaqBILLERICA, Mass., November 22, 2024--Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the "Notice") on November 21, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Form 10-Q"), it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires listed companies to timely file all required periodic financial |
Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ...Quanterix Corp (QTRX) reports its sixth consecutive quarter of double-digit revenue growth, despite facing hurdles in instrument sales and regional revenue declines. |
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024BILLERICA, Mass., November 12, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial results for the third quarter ended September 30, 2024 and reaffirmed its full year 2024 guidance. The Company also disclosed the need to restate certain prior period financial statements to correct non-cash errors related to those periods. |
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024BILLERICA, Mass., November 05, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Tuesday, November 12, 2024, at 4:30 p.m. E.T., to discuss third quarter 2024 financial results. |